Form 4: Alan B. Miller, Executive Chairman of Universal Health Services, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Alan B. Miller, Executive Chairman of Universal Health Services, reports transactions involving Class B Common Stock, including acquisitions from vested restricted stock units and option exercises, as well as dispositions to cover tax obligations.
Summary
- Alan B. Miller, the Executive Chairman of Universal Health Services, filed a Form 4 detailing changes in his beneficial ownership of the company's Class B Common Stock.
- On March 12, 2025, Miller acquired 26,076 shares upon the vesting of performance-based restricted stock units (RSUs) at a price of $0.
- Also on March 12, 2025, Miller disposed of 11,080 shares at $166.61 to cover tax obligations.
- On March 13, 2025, Miller exercised options to purchase 117,933 shares at $74.46 and 96,667 shares at $67.69.
- On March 13, 2025, Miller disposed of 144,927 shares at $163.99 to cover tax obligations.
- Following these transactions, Miller directly owns 1,363,399 shares of Class B Common Stock.
- Miller also has indirect ownership through various trusts and LLCs.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and does not necessarily indicate a positive or negative outlook for the company.
Positives
- The vesting of performance-based RSUs indicates that the company met certain performance criteria.
- Executive Chairman Miller increased his direct ownership of Class B Common Stock through option exercises.
Negatives
- The disposition of shares to cover tax obligations may be seen as a slight negative, although it's a common practice.
Risks
- Significant stock transactions by insiders could potentially create short-term price volatility.
Management Comments
- Mr. Alan B. Miller disclaims beneficial ownership of certain securities held in trusts and LLCs, and this report shall not be deemed an admission that Mr. Alan B. Miller is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Industry Context
Insider transactions are closely watched by investors as they can provide insights into management's perspective on the company's prospects. This Form 4 filing is a routine disclosure required by the SEC.
Comparison to Industry Standards
- Form 4 filings are standard practice for executives and major shareholders in publicly traded companies.
- The transactions reported are typical for executives who receive stock options and restricted stock as part of their compensation packages.
- Similar filings can be observed for executives at comparable healthcare companies like HCA Healthcare and Tenet Healthcare.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders.
- Shareholders may be interested in the insider's perspective, but the transactions are primarily related to compensation.
Key Dates
| Date | Description |
|---|---|
| 03/18/2021 | Option vested ratably |
| 03/18/2022 | Option vested ratably |
| 03/23/2022 | Date of RSU award to Reporting Person |
| 03/18/2023 | Option vested ratably |
| 03/18/2024 | Option vested ratably |
| 03/12/2025 | Acquisition of shares from vested RSUs and disposition of shares for tax obligations. |
| 03/13/2025 | Exercise of options and disposition of shares for tax obligations. |
| 03/14/2025 | Date of Form 4 filing. |
| 03/17/2025 | Option Expiration Date |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.